Cartesian Therapeutics
RNAC
#8958
Rank
โ‚น17.35 B
Marketcap
โ‚น568.93
Share price
4.24%
Change (1 day)
-12.29%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -โ‚น4.75 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚น1.47 Million. In 2025 the company made an earning of -โ‚น4.55 Billion a decrease over its 2024 earnings that were of -โ‚น2.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น4.75 Billion4.39%
2025 -โ‚น4.55 Billion80.63%
2024 -โ‚น2.52 Billion-88.5%
2023 -โ‚น21.86 Billion-724%
2022 โ‚น3.50 B-649.67%
2021 -โ‚น0.64 Billion-89.78%
2020 -โ‚น6.24 Billion25.06%
2019 -โ‚น4.99 Billion-15.68%
2018 -โ‚น5.92 Billion-0.43%
2017 -โ‚น5.95 Billion83.41%
2016 -โ‚น3.24 Billion44.3%
2015 -โ‚น2.25 Billion